Director, QA Compliance
Greater Los Angeles Area
Director, QA Compliance
Greater Los Angeles Area
Quality Director working with biotechnology and pharmaceutical companies in Quality Systems, Compliance, Project Management, Business Analysis, Validation, and Quality Assurance functions with strong understanding of the drug development process, clinical trials support, and regulatory requirements.
Quality and regulatory compliance specialist with expertise in development and implementation of quality systems, procedures, and business practices that comply with FDA, ICH, QSR, ISO, GMP, GLP, GCP, GAMP, 21 CFR Part 11, and international standards.
Certified lead auditor with significant expertise in internal audits of clinical and commercial quality systems, and external audits of contract manufacturing organizations, contract laboratories, contract research organizations, material suppliers, service vendors, and IT services and software providers.
Validation specialist, business analyst, and project manager with working knowledge of enterprise-wide software systems, laboratory and manufacturing equipment, research and manufacturing facility start-up. Computer systems validation (CSV) through full software development life cycle for pharamceutical business processes, clinical data capture, and supply chain management.
Develop and implement quality systems; vendor audits; inspection readiness; regulatory compliance; clinical trials support
Enterprise-wide custom/COTS software validation: LIMS, SAP ERP, EDMS, EDC, CDS, LiveLink, Documentum, ISOTrain, ComplianceWire, Trackwise, CalMan, Argus Safety, Oracle AERS, Oracle Clinical, MedDRA, eQCM, SAS, IVRS, Chemstation, SoftMax
Equipment and facilities validation: LC, GC, LCMS, CE, TOC, ELISA, HVAC, WFI, BMS, stability, process equipment, cleaning
(Public Company; Pharmaceuticals industry)
August 2008 — Present (1 year 4 months)
(Privately Held; Biotechnology industry)
March 2007 — Present (2 years 9 months)
(Public Company; ELN; Pharmaceuticals industry)
2001 — 2007 (6 years )
(Privately Held; Biotechnology industry)
2001 — 2003 (2 years )
(Educational Institution; Higher Education industry)
1999 — 2001 (2 years )
Thesis: Effects of high carbohydrate and high long chain fatty acid availability on skeletal muscle fatty acid metabolism and regulation of substrate oxidation
(Public Company; JNJ; Pharmaceuticals industry)
1995 — 1999 (4 years )
(Public Company; 51-200 employees; Biotechnology industry)
1994 — 1995 (1 year )
MS , Physiology , 1999 — 2002
BS , Systems Physiology , 1990 — 1994